28 July 2020 Analysis
Gavi’s COVAX Facility and associated AMC aims to facilitate fair access to Covid-19 vaccines. However, global health charity MSF has apprehensions about various elements of the initiative, primarily linked to...
27 July 2020 Analysis
The only way the Covid-19 pandemic can be brought to an end is if everyone across the world has access to the right diagnostics, treatments, and importantly, vaccines. So the...
16 July 2020 Analysis
Covid-19 is not the only public health threat facing the world. Drug-resistant bacterial infections have the potential to kill 10 million people a year by 2050 unless there are serious...
15 July 2020 Analysis
It is astounding how quickly Covid-19 vaccines have progressed into and through clinical trials. However, there are concerns that these vaccines may not be particularly effective at preventing Covid-19 infections...
14 July 2020 Analysis
Most of us can’t wait for summer, but it’s a tricky time for those with seasonal allergies such as hay fever. Natalie Healey examines the challenges facing drug development in...
10 July 2020 News
Approved COVID-19 vaccine could be available in six months; high-risk groups should get priority access: Poll
The global spread of the COVID-19 pandemic and the resulting economic impact and public health burden has highlighted the urgent need for a vaccine to prevent the disease
8 July 2020 Analysis
Virtualised clinical trials have become more commonplace amid the Covid-19 pandemic as a mechanism through which pharma companies can avoid delaying or cancelling their trials. The standard approach from the...
7 July 2020 Analysis
Most drugs being repurposed for Covid-19 focus on the more severe, later stages of the disease and preventing deaths among the worst-affected patients. However, PTC’s experimental oncology drug PTC299 has...